About Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia
Clinical Trials at Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia
During the past decade, Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia"
#1 collaborator was "Bayer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia
According to Clinical.Site data, the most researched conditions in "Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia" are
"Castration-Resistant Prostatic Cancer" (1 trials), "Locally Advanced Metastatic NSCLC" (1 trials), "Locally Advanced Unresectable NSCLC" (1 trials), "Lung Cancer" (1 trials) and "Lymphoma, Mantle-Cell" (1 trials). Many other conditions were trialed in "Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia" in a lesser frequency.
Clinical Trials Intervention Types at Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia
Most popular intervention types in "Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "AMG 510" (1 trials), "Abiraterone Acetate" (1 trials), "Bortezomib" (1 trials), "Darolutamide" (1 trials) and "Ibrutinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia
The vast majority of trials in "Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia" are
3 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia
Currently, there are NaN active trials in "Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".